Cargando…

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency of international concern. Modified vaccinia Ankara—Bavarian Nordic (MVA-BN, also known as Imvamune, JYNNEOS or Imvanex) is a third-generation smallpox vaccine that is authorized and in use as a vaccine against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaeck, Luca M., Lamers, Mart M., Verstrepen, Babs E., Bestebroer, Theo M., van Royen, Martin E., Götz, Hannelore, Shamier, Marc C., van Leeuwen, Leanne P. M., Schmitz, Katharina S., Alblas, Kimberley, van Efferen, Suzanne, Bogers, Susanne, Scherbeijn, Sandra, Rimmelzwaan, Guus F., van Gorp, Eric C. M., Koopmans, Marion P. G., Haagmans, Bart L., GeurtsvanKessel, Corine H., de Vries, Rory D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873555/ https://www.ncbi.nlm.nih.gov/pubmed/36257333 http://dx.doi.org/10.1038/s41591-022-02090-w

Ejemplares similares

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein
por: Raadsen, Matthijs P, et al.
Publicado: (2023)

Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2022)

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person
por: Munnink, Bas B. Oude, et al.
Publicado: (2022)

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
por: Rockx, Barry, et al.
Publicado: (2020)

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
por: Mooij, Petra, et al.
Publicado: (2022)

Asymptomatic Mpox Virus Infection in Subjects Presenting for MVA-BN Vaccine
por: Matusali, Giulia, et al.
Publicado: (2023)

Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
por: Embregts, Carmen W.E., et al.
Publicado: (2021)

Low Virulence and Lack of Airborne Transmission of the Dutch Highly Pathogenic Avian Influenza Virus H5N8 in Ferrets
por: Richard, Mathilde, et al.
Publicado: (2015)

Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
por: Mykytyn, Anna Z., et al.
Publicado: (2022)

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
por: Raadsen, Matthijs P., et al.
Publicado: (2021)

Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022
por: Berens-Riha, Nicole, et al.
Publicado: (2022)

Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus–infected mice
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2009)

Both Conventional and Interferon Killer Dendritic Cells Have Antigen-Presenting Capacity during Influenza Virus Infection
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2009)

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
por: Bockstal, Viki, et al.
Publicado: (2022)

From more testing to smart testing: data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020
por: van Beek, Janko, et al.
Publicado: (2022)

Brain stem encephalitis is a rare complication of COVID-19
por: Shamier, Marc C., et al.
Publicado: (2023)

T cells and ILC2s are major effector cells in influenza‐induced exacerbation of allergic airway inflammation in mice
por: Li, Bobby W. S., et al.
Publicado: (2018)

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2020)

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
por: Kreijtz, Joost H. C. M., et al.
Publicado: (2009)

Dried blood spot cards: A reliable sampling method to detect human antibodies against rabies virus
por: Doornekamp, Laura, et al.
Publicado: (2020)

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
por: Geers, Daryl, et al.
Publicado: (2021)

Whole-Blood Testing for Diagnosis of Acute Zika Virus Infections in Routine Diagnostic Setting
por: Voermans, Jolanda J.C., et al.
Publicado: (2019)

Clearance of influenza virus from the lung depends on migratory langerin(+)CD11b(−) but not plasmacytoid dendritic cells
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2008)

SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence
por: den Hartog, Gerco, et al.
Publicado: (2020)

Bias induced up to 100% spin-injection and detection polarizations in ferromagnet/bilayer-hBN/graphene/hBN heterostructures
por: Gurram, M., et al.
Publicado: (2017)

Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
por: Tan, Ngoc H., et al.
Publicado: (2022)

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
por: DeMaria, Peter J, et al.
Publicado: (2021)

Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
por: Jordan, Elke, et al.
Publicado: (2023)

SARS-CoV-2 is transmitted via contact and via the air between ferrets
por: Richard, Mathilde, et al.
Publicado: (2020)

LB1579. A single and a two-dose regimen of MVA-BN elicit similar memory responses to a boost vaccination two years after the initial regimen, indicating potential flexibility for a delayed second dose of MVA-BN in the ongoing monkeypox emergency
por: Weidenthaler, Heinz, et al.
Publicado: (2022)

Publisher Correction: Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Specific memory B cell response in humans upon infection with highly pathogenic H7N7 avian influenza virus
por: Westerhuis, Brenda, et al.
Publicado: (2020)

Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen
por: Bockstal, Viki, et al.
Publicado: (2021)

Reassortment between Avian H5N1 and Human Influenza Viruses Is Mainly Restricted to the Matrix and Neuraminidase Gene Segments
por: Schrauwen, Eefje J. A., et al.
Publicado: (2013)

Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice
por: Beicht, Jana, et al.
Publicado: (2023)

ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
por: Lamers, Mart M., et al.
Publicado: (2019)

High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients
por: Hoek, Rogier AS, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_69f9go94plj7ihn3oc7jgu53rp